SciELO - Scientific Electronic Library Online

 
vol.30 número6Abordagem atual à disfagia: Uma revisão dos distúrbios da motilidade esofágica e respetivo tratamentoO Novo Fibroscan-AST (FAST) Score: Reforçando o Impacto da Diabetes Mellitus no Fígado Gordo Associado a Disfunção Metabólica índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


GE-Portuguese Journal of Gastroenterology

versão impressa ISSN 2341-4545

GE Port J Gastroenterol vol.30 no.6 Lisboa dez. 2023  Epub 01-Fev-2024

https://doi.org/10.1159/000526852 

Research Article

Technical and Clinical Outcomes of Using a Single Wide-Caliber Double-Pigtail Stent for Endoscopic Ultrasound-Guided Pancreatic Pseudocyst Drainage: A Multicenter Prospective Study

Resultados Técnicos e Clínicos da Utilização de Stent Duplo Pigtail de Grande Calibre para Drenagem Endoscópica de Pseudoquistos Pancreáticos: Estudo Prospetivo Multicêntrico

Elsayed Ghoneem1  2 

Hussein Okasha3 

Mohamed Hammouda1 
http://orcid.org/0000-0001-6439-9442

Mohamed Fathi Gouda4 

Reham Soliman1  5 
http://orcid.org/0000-0002-4562-9748

Gamal Shiha1  2 

Khaled Ragab4 

Ramy Hassan Agwa1 

1Hepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt;

2Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt;

3Hepatology and Gastroenterology Unit, Kasr al-Aini School of Medicine, Cairo University, Cairo, Egypt;

4Theodor Bilharz Research Institute, Cairo, Egypt;

5Tropical Medicine Department, Faculty of Medicine, Port Said University, Port Said, Egypt


Abstract

Introduction:

Endoscopic ultrasound (EUS)-guided pancreatic cysto-gastrostomy/duodenostomy is the current accepted practice for management of symptomatic pancreatic pseudocysts with insertion of two or more double-pig-tail (DP) stents. There is no much work on the efficacy of using a single wide-caliber DP stent, aiming to decrease the time, complications, and accessories used in the procedure.

Aim of the Work:

The aim of this study was to assess technical and clinical outcomes of using a single wide-caliber DP stent in EUSguided pancreatic pseudocyst drainage.

Methodology:

This multicenter prospective study included 57 patients, from which the 35 patients with symptomatic pancreatic pseudocysts enrolled. Patients with cysts with mul-tiple septations (7 cases) or cyst with >30% necrosis (8 cases) of the cyst content and patients with generalized ascites (4 cases) or patients with major comorbidities (3 cases) were excluded. Patients were followed up within 1 month and 6 months after stent placement to assess complete resolution or a decrease in the sizes of cysts with clinical symptomatic improvement.

Results:

From 57 patients, 35 patients (19 females/16 males, median age 40 years) with a symptomatic pancreatic pseudocyst were referred for EUS-guided drainage. All used stents were 10 Fr DP plastic stents. The median duration of the whole procedure was 16 min. Technical success was achieved in all cases. Clinical success was encountered in 32 patients (91.4%) without re-accumulation on follow-up. Minor adverse events were encountered in 3 patients (8.6%) including post-procedure abdominal pain (1 case) and fever (2 cases).

Conclusion:

We suggest that using a wide-caliber single-pigtail stent for EUS-guided cystogastrostomy is safe and effective with short procedure time, with reduced risks from the insertion of another stent(s).

Keywords: Endoscopic ultrasound; Pancreatic pseudocyst; Pancreatitis; Cystogastrostomy; Single double-pigtail

Resumo

Introdução:

A cistogastrostomia/duodenostomia pancreática guiada por ecoendoscopia (EUS) é atualmente aceite para a abordagem dos pseudoquistos pancreáticos sintomáticos através da inserção de dois ou mais stents duplo pigtail (DP). A evidência é escassa relativamente à eficácia da utilização de apenas um stent duplo pigtail de grande calibre, com o objetivo de diminuir o tempo, as complicações e os dispositivos utilizados no procedimento.

Objetivo:

Avaliar os resultados técnicos e clínicos do uso de stent duplo pigtail único de grande calibre na drenagem de pseudoquistos pancreáticos guiada por ecoendoscopia. Metodologia: Estudo prospetivo multicêntrico incluindo 57 doentes (dos quais 35 com pseudoquistos pancreáticos sintomáticos). Foram excluídos pacientes com quistos multiseptados (7 casos), com necrose >30% (8 casos), com ascite (4 casos) e comorbidades major (3 casos). O follow-up foi ao 1 mês e 6 meses após a colocação do stent para avaliar a resolução completa ou diminuição no tamanhos dos pseudoquistos com melhoria sintomática.

Resultados:

Dos 57 doentes, 35 (19 mulheres/16 homens, idade média 40 anos) com pseudoquistos pancreáticos sintomáticos foram submetidos a drenagem guiada por EUS. Todos os stents utilizados foram stents DP plásticos com 10 Fr. A duração mediana do procedimento foi de 16 minutos. O sucesso técnico foi alcançado em todos os casos. Ocorreu sucesso clínico em 32 doentes (91,4%), sem reacumulação no seguimento. Eventos adversos menores ocorreram em 3 doentes (8,6%), incluindo dor abdominal pós-procedimento (1) e febre (2).

Conclusão:

Os resultados sugerem que a utilização de stent pigtail único de grande calibre para cistogastrostomia guiada por EUS é segura e eficaz, com tempo de procedimento curto e reduzindo o risco da inserção de outro(s) stent(s).

Palavras Chave: Ecoendoscopia; Pseudoquisto pancreático; Pancreatite; Cistogastrostomia; Stent plástico

Introduction

Pancreatic and peripancreatic collection (PPC) is a common complication of acute and chronic pancreatitis. The incidence of PPC in acute pancreatitis is 5-16%; however, in chronic pancreatitis, it may reach 20-40% [1-4]. The majority of peripancreatic fluid collections complicating acute pancreatitis usually resolve spontaneously within 4-6 weeks of the onset of the attack [5]. Nevertheless, PPC associated with chronic pancreatitis might resolve spontaneously only in a minority of cases [6].

According to duration and amount of necrosis, PPC is categorized into four types: acute peripancreatic fluid collection, pseudocyst, acute necrotic collection, and walled-off necrosis (WON) [7]. The unresolved PPC may be asymptomatic or present with epigastric pain, dyspepsia, fever, gastric outlet obstructive symptoms, or biliary obstruction [8]. Symptomatic and long-term unresolved PPC are the common indications for drainage [9].

Unresolved symptomatic PPC management has evolved dramatically over recent years from surgical or percutaneous drainage into minimal-invasive endoscopic approaches [10]. EUS-guided drainage is the favored approach in current management algorithms, having better outcomes compared to non-guided endoscopic, percutaneous, or surgical drainage approaches [11].

For evaluation of PPC, EUS is the preferred method since it can accurately measure the distance between the GI lumen and the pseudocyst with delineation of a safe nonvascular window for drainage using Doppler US [12, 13]. Likewise, the choice of the stent type used for drainage can be directly influenced by the nature of the fluid content detected by EUS. EUS evaluation of the wall might also affect management decision with the necessity to pre-drainage clarification of diagnosis using EUS-FNA when suspecting cystic neoplasms with focally enlarged/thickened wall [14].

Regarding that EUS-guided transmural drainage needs multiple steps and lots of resources, it would be more wise and efficient if the number of steps is to be minimized, providing shorter time for the procedure as well as using fewer resources while maintaining the efficacy and patient safety of the procedure. A systematic review by Bang et al. [15] concluded that current evidence does not favor routine placement of metal stents over conventional plastic stents for transmural drainage of PPC. Additionally, there is a conflict in current practice about the number and caliber of the plastic stents for EUS-guided drainage of PPC [16]. We tried in this study to alleviate this conflict about the sufficient number of plastic stents needed for pancreatic pseudocyst drainage and evaluate the efficacy of using only one wide-diameter double-pigtail (DP) plastic stent.

Methods

This is a multicenter prospective study for cases of EUS-guided PPC drainage in the endoscopy units of four tertiary centers be-tween January 2017 and February 2020. Patients with symptomatic pancreatic pseudocyst that unresolved for at least 6 weeks after the last episode of pancreatitis were included in this study (Fig. 1). We excluded patients with major comorbidities being unfit for general anesthesia (3 cases), those with multiple cyst septation (7 cases), or >30% necrosis of the cyst content (8 cases) and patients with moderate to marked abdominal free fluid (4 cases). Patients’ medical data were recruited including detailed history for symptoms of pancreatitis (epigastric pain radiating to the back), onset, duration, severity, and possible etiology of pancreatitis (alcoholic, biliary, etc.), basic laboratory investigations, and radiological evaluation including abdominal ultrasound, contrastenhanced CT and or MRCP. Before EUS-guided intervention, cyst fluid analysis (fluid amylase, CEA, and cytological examination) was achieved for confirmation of the diagnosis of PPC.

Fig. 1. Flowchart summarizing study population. 

The procedure time was defined as the elapsed time from the first image of the lesion for the EUS procedure which was obtained to the confirmed image of placement of the pigtail stent into the cyst. Technical success was defined as successful and appropriate placement of the DP stent in the transmural tract. Follow-up examinations, including CT, were performed within 1 month after stent placement to assess complete resolution or a decrease in the sizes of cysts with clinical symptomatic improvement. Treatment success (or clinical success) was defined as a partial (reduction of > 50% of the large axis) to complete resolution of the drained cysts with symptomatic improvement on follow-up CT at 4 weeks.

Endoscopic Procedure and Outcome Assessment

EUS-guided drainage was performed by three experienced endosonographers with long experience in the field of therapeutic EUS using linear-type echoendoscope (Pentax EG-3870UTK “PENTAX Medical, Tokyo, Japan, attached to a Hitachi - Aloka Avius processor “Hitachi, Tokyo, Japan” and Fujifilm EG-580UT “Fujifilm Global, Tokyo, Japan” with SU-1) in all cases with the deployment of one 10 Fr DP plastic stent either through the transgastric or transduodenal approach. Technical success was defined as successful transmural stent placement into the PPC, while clinical success was an improvement of symptoms and resolution of the fluid collection or decrease for more than 50% as determined by contrastenhanced CT performed 1 month after the procedure without recurrence after stent removal within the follow-up period (6 months from the procedure). The detailed technique, duration of the procedure, related complications, and intraoperative complications (bleeding, perforation, leak, stent mal-deployment, or migration) were assessed. Also, early postoperative complications like pain, fever, nausea, vomiting, peritonitis, or pneumoperitoneum and late complication like stent migration, recurrence, pancreatitis were reported. The procedure technique involved EUS characterization of the PPC regarding size, wall thickness, distance from the GI lumen, percent of solid components, exclusion of mural nodules, and choosing the shortest vascular free tract for possible drainage. Subsequently, puncturing of the pancreatic pseudocyst wall was achieved in all cases using a 19-gauge FNA needle under the guidance of the Doppler US, followed by confirmatory aspiration of the content. Afterward, a 0.035-inch guidewire was inserted through the needle into the pseudocyst lumen, forming 2-3 coils under both EUS and fluoroscopy guidance to prevent any potential dislodgment. Furthermore, graded dilatation of the needle tract was achieved using electrocautery (6 or 10 Fr cystotome or needle knife) followed by dilatation using either a 10 Fr Soehendra dilator (Soehendra® Biliary Dilation Catheter) or dilatation balloon of different sizes, 10-11-12 or 12-13.5-15 (Cook® Hercules Dilation Balloon or Boston Scientific® CRE balloon). Finally, under the guid ance of EUS and fluoroscopy, a wide-caliber, 10 Fr DP plastic stent was deployed over the guidewire into the pancreatic pseudocyst with the consequent flow of the content into the GI lumen under an endoscopic view, confirming a successful technique (Fig. 2). All procedures were done under general anesthesia with endotracheal intubation, while the patient is in the left lateral position.

Fig. 2. a-f Steps for EUS-guided cystogastrostomy. 

Statistical Analysis

Summary statistics were used to describe the characteristics of the study population (median, ranges for describing quantitative variables, frequency, and percentage for categorical variables). The Mann-Whitney U test was used to compare continuous variables, while χ2 and Fisher’s exact tests were used to compare categorical and dichotomous variables between study subgroups. Logistic regression was used to detect the independent factors affecting clinical outcomes. All statistical analyses were performed using IBM® SPSS software (version 23) for Windows. p value was evaluated as two-tailed, and significance was established at a p < 0.05 level.

Results

Study Population Baseline Characteristics

A total of 57 patients diagnosed with PPC were re-ferred for EUS-guided pseudocyst drainage. Twenty-two patients were excluded (3 patients with major comorbidities, 7 had multiple cyst septation, eight cases had >30% necrosis of the cyst content, and 4 patients with moderate to marked abdominal free fluid). Thirty-five patients were enrolled (19 females/16 males, median age 40 years, range; 3-73), and patient and clinical characteristics are demonstrated in Table 1. While most of the patients were referred directly to EUS drainage, only 4 (11.4%) patients experienced a prior failed trial of percutaneous drainage approach. Idiopathic pancreatitis was the most common etiology (n = 19, 54.3%) followed by biliary (n = 5, 14.3%), post-traumatic (n = 4, 11.4), two post-chemotherapy for acute lymphocytic leukemia, and one case of alcoholic, post-distal pancreatectomy, postsplenectomy, post-ERCP, and primary hyperparathyroidism. All the patients were symptomatic with abdominal pain as the most common symptom (n = 24, 68.6%), early satiety, and dyspepsia in (n = 10, 28.6%) in addition to 1 patient who presented with a picture of gastric outlet obstruction and persistent vomiting.

Table 1. Patient baseline characteristics and endoscopic therapy details 

Endoscopic Details and Outcomes

Most of the PPCs were located at the pancreatic body (n = 31, 88.6%). The median size of PPC was 10 cm (range; 5-20) with most of patients >10 cm (n = 20, 57.1%). Median percentage of necrosis within PPCs was 5% (range; 0-30) with 19 patients (54.3%) ≤5%, 16 (42.8%) between 5 and 25% and 1 patient with 30% necrotic area. All patients had a periprocedural antibiotic course of 3rd gen eration cephalosporins or quinolones with a median period of 5 days (range; 3-20). EUS drainage through the transgastric route was the predominant procedure (n = 33, 94.3%). All stents used for the drainage were 10 Fr DP plastic stents with 10, 7, and 5 cm lengths. Electrocautery cystotome (6 or 10 Fr) were used for primary tract dilatation in 33 patients (94.3%) and precut needle in only 2 patients (5.7%). Subsequent dilatation of the needle tract was achieved in 33 patients using a Soehendra dilator 10 Fr alone in (n = 14, 40%), dilation balloon (median 8 mm, range; 4-15) in (n = 9, 25.7%), or subsequent dilatation by both in (n = 10 patients, 28.6%). The median duration of the whole procedure in 34 patients was 16 min (range; 13.5-27), and only one case with mal-deployment of the stent into the lumen of the cyst completed using another stent within 40 min.

Technical success was achieved in all the cases despite few difficulties encountered in 5 patients including difficult access in the duodenal bulb in 2 patients, small-sized stomach in one child case (3 years old), shearing of the wire with the need to repuncture in one case, and a mal-deployed stent into the PPC lumen in 1 patient. Nonetheless, clinical success was encountered in 32 patients (91.4%) with the improvement of patient symptoms and resolution of the cyst without re-accumulation on follow-up. The three failed cases had a relapse of the cyst after an initial good response with the need for re-intervention in 1 patient with percutaneous drainage and repeated EUS-cystogastrostomy in another patient. The third patient of the failure group was misdiagnosed as pancreatic pseudo-cyst due to misleading laboratory data of cyst fluid analysis with re-accumulation after early good symptomatic response. The repeated analysis revealed a diagnosis of mucinous cystic neoplasm and ultimately the patient died with liver metastasis. In addition to the three cases with clinical failure, minor post-procedure adverse events were encountered in 3 patients (8.6%) including post-procedure abdominal pain in 1 patient which improved gradually and fever in 2 patients with resolution after conservative management including antipyretics and broad-spectrum antibiotics. No perforations or bleeding were encountered.

Comparison between clinical success and failure sub-groups revealed no significant difference regarding patient clinical data and PPC characteristics (Table 2). Also, multivariable logistic regression showed no independent factors affecting clinical success (Table 3).

Table 2. Outcome in studied population 

Table 3. Multivariable logistic regression for clinical success 

Discussion

This study showed that the management of symptomatic pancreatic pseudocyst by EUS-guided cystogastrostomy with the insertion of a wide-caliber single-pigtail plastic stent is technically feasible, safe, and effective and leads to shorter procedure time. As the general trend in most medical procedures nowadays is evolving toward the easiest, short duration, minimally invasive, fewer resources consuming with the highest efficacy approaches, our study revealed that using one wide-diameter DP plastic stent for symptomatic pseudocyst drainage was safe and effective. In our patients, we had faced only minor adverse events in 3 patients (8.5%) including fever and post-procedure abdominal pain; both have resolved with conservative treatment.

Technical success was achieved in all cases (100%) of our cases with the insertion of a transmural pigtail stent despite the difficulties encountered in few cases (those with transduodenal route) which emphasize the easiness of the technique with decreasing the number of approach steps using only one stent. Clinical success was achieved in 91.4% of our patients with the resolution of patients’ symptoms and no recurrence of a cyst with follow-up after 1 month, 6 months, and 12 months. Our study showed a recurrence rate of 5.7% after an initial good response which needs reintervention (one repeated endoscopic cystogastrostomy and the second underwent percutaneous drainage). This matched with the results of a systemic review that analyzed the mean clinical and technical success of 56 studies (each enrolled more than 10 patients Regarding data using a single-pigtail stent, our results go in line with data reported by retrospective studies showing that drainage of PPC and procedure-related adverse events are not affected by the number or size of used stents and that a single stent may be enough for safe effective drainage [16, 17]. Lin et al. [16] found that clinical success for using a single stent was 93.9% (46/49) versus 97.4% (37/38) for multiple stents (p = 0.799). Secondary infection for single-stent drainage was more than multiple stents (18.4% vs. 5.3%) (p = 0.134). Secondary infection also was more for stent diameter 10 F or more versus 8.5 F or less (17.2% vs. 3.4%; single or more stents) (p = 0.138). Bang et al. [17] also evaluated the number and size of the plastic stent with the treatment outcome in 122 patients, and they found that no relationship between the number or the size of the stent with the treatment success or number of re-intervention (overall success was 94.3%, 83.6% with one intervention and 10.7% with re-intervention and 5.7% failed endoscopic treatment).

Our study has included symptomatic patients with unresolved PPC for more than 6 weeks enabling the cyst wall to be well-defined. The main etiologies for acute pancreatitis and related complication worldwide are gall-stones and alcoholism [18]. Most of our cases had idiopathic or biliary etiologies (68.6%). Alcoholism as a cause of pancreatitis is not so common in the Egyptian population due to the lower incidence of alcoholism in Egyptian society.

The transgastric drainage was regarded as the most common drainage site [19] which is consistent with our study with 94.3% of patients underwent transgastric PPC drainage. Regarding needle tract dilatation, a single-center retrospective study by Kitamura et al. [20] has shown that the use of electrocautery dilator for the needle tract during PPC drainage was shown to be safe and effective. These data have favored the use of cautery dilatation for all cases in our study which in turn has facilitated stent deployment without major related adverse events. Also, the use of electrocautery as the first dilatation device can fasten the procedure. This matched with Kitamura et al. [20] that showed a significant difference in procedure time between the electrocautery group (with mean time 30 ± 12 min) than non-electrocautery group (52 ± 20 min).

All included patients received periprocedural antibi otic course of 3rd generation cephalosporins or quino-lones for a median period of 5 days. While broadspec trum antibiotics are strongly recommended for patients with an infected pseudocyst either empirically or based on culture sensitivity [21], its prophylactic role for non-infected pseudocyst has not been studied [7].

The median duration of the procedure in most cases was 16 min (range; 13.5-27). This short procedure time is mostly related to the insertion of one stent rather than multiple stents. Multiple-stent placement is more difficult, takes a longer time, and has a higher risk of complications.

Regarding hospital stay, the median hospital stay was 3 days (2-7 days). However, in Lin et al.’s [16] work, the mean length of hospital stay was 9.9 ± 10.1 days (range 1-50 days). The short hospital stay in our study is due to exclusion of patients with WON and cyst with more than 30% necrosis, and this indicates the safety and less complication related to the procedure.

Despite our study was prospective and multicenter, we have some limitations including a relatively small number and single-armed protocol. A large number of randomized controlled studies are needed. In conclusion, management of symptomatic pancreatic pseudo-cyst by EUS-guided cystogastrostomy with the insertion of a wide-caliber single-pigtail plastic stent is technically feasible, safe, and effective with short procedure time.

Key Summary

  • • There is a conflict in current practice about the number and caliber of the plastic stents for EUS-guided drainage of PPC.

  • • Drainage using multiple plastic stents may be time-consuming with the consumption of more accessories through multiple dedicated steps with increased risk of complications and loss of access during the exchange procedures.

  • • The use of a single wide-caliber DP stent is technically feasible and effective with high clinical success and reduced procedure steps with less time, accessories, and complications.

References

1. Baillie J. Pancreatic pseudocysts (part I). Gastrointest Endosc. 2004; 59(7): 873-9. [ Links ]

2. Elliott DW. Pancreatic pseudocysts. Surg Clin North Am. 1975; 55(2): 339-62. [ Links ]

3. Barthet M, Bugallo M, Moreira LS, Bastid C, Sastre B, Sahel J. Management of cysts and pseudocysts complicating chronic pancreatitis. A retrospective study of 143 patients. Gastroenterol Clin Biol. 1993; 17(4): 270-6. [ Links ]

4. Kim KO, Kim TN. Acute pancreatic pseudocyst: incidence, risk factors, and clinical outcomes. Pancreas. 2012; 41(4): 577-81. [ Links ]

5. Brun A, Agarwal N, Pitchumoni CS. Fluid collections in and around the pancreas in acute pancreatitis. J Clin Gastroenterol. 2011; 45(7): 614-25. [ Links ]

6. Rosso E, Alexakis N, Ghaneh P, Lombard M, Smart HL, Evans J, et al. Pancreatic pseudocyst in chronic pancreatitis: endoscopic and surgical treatment. Dig Surg. 2003; 20(5): 397- 406. [ Links ]

7. Pereira F, Caldeira A, Leite S, Marques S, Moreira T, Moutinho-Ribeiro P, et al. GRUPUGE perspective: endoscopic ultrasoundguided drainage of peripancreatic collections. GE Port J Gastroenterol. 2020; 28(1): 39-51. [ Links ]

8. Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017; 62(7): 1745-50. [ Links ]

9. Yip HC, Teoh AYB. Endoscopic management of peri-pancreatic fluid collections. Gut Liver. 2017; 11(5): 604-11. [ Links ]

10. Shahid H. Endoscopic management of pancreatic fluid collections. Transl Gastroenterol Hepatol. 2019; 4: 15. [ Links ]

11. Bang JY, Varadarajulu S. Endoscopic ultrasound-guided management of pancreatic pseudocysts and walled-off necrosis. Clin Endosc. 2014; 47(5): 429-31. [ Links ]

12. Fockens P. EUS in drainage of pancreatic pseudocysts. Gastrointest Endosc. 2002; 56(4 Suppl l): S93-7. [ Links ]

13. Giovannini M. EUS-guided pancreatic pseudocyst drainage. Tech Gastrointest Endosc. 2007; 9(1): 32-8. [ Links ]

14. Saftoiu A, Vilmann A, Vilmann P. Endoscopic ultrasound-guided drainage of pancreatic pseudocysts. Endosc Ultrasound. 2015; 4: 319-23. [ Links ]

15. Bang JY, Hawes R, Bartolucci A, Varadarajulu S. Efficacy of metal and plastic stents for transmural drainage of pancreatic fluid collections: a systematic review. Dig Endosc. 2015; 27(4): 486-98. [ Links ]

16. Lin H, Zhan XB, Sun SY, Yang XJ, Jin ZD, Zou DW, et al. Stent selection for endoscopic ultrasound-guided drainage of pancreatic fluid collections: a multicenter study in China. Gastroenterol Res Pract. 2014; 2014: 193562. [ Links ]

17. Bang JY, Wilcox CM, Trevino JM, Ramesh J, Hasan M, Hawes RH, et al. Relationship between stent characteristics and treatment outcomes in endoscopic transmural drainage of uncomplicated pancreatic pseudocysts. Surg Endosc. 2014; 28(10): 2877-83. [ Links ]

18. Chatila AT, Bilal M, Guturu P. Evaluation and management of acute pancreatitis. World J Clin Cases. 2019; 7(9): 1006-20. [ Links ]

19. Yusuf TE, Baron TH. Endoscopic transmural drainage of pancreatic pseudocysts: results of a national and an international survey of ASGE members. Gastrointest Endosc. 2006; 63(2): 223-7. [ Links ]

20. Kitamura K, Yamamiya A, Ishii Y, Nomoto T, Honma T, Yoshida H. Electrocautery versus non-electrocautery dilation catheters in endoscopic ultrasonography-guided pancreatic fluid collection drainage. World J Gastrointest Endosc. 2016; 8(13): 458-65. [ Links ]

21. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis: 2012 - evision of the Atlanta classification and definitions by international consensus. Gut. 2013; 62(1): 102-11. [ Links ]

1Statement of Ethics The study protocol was approved by the Research and Ethical Committee of Egyptian Liver Research Institute and Hospital (EL-RIAH, IORG #0008819) IRB00010534. The protocol and conduct of the study complied with the International Ethical Guidelines for Biomedical Research Involving Human Subjects, with its amendments in 2008. Written informed consent was obtained from each patient.

3Funding Sources This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

5Data Availability Statement All data generated or analyzed during this study are included in this published article and readily available for share.

Received: January 09, 2022; Accepted: March 25, 2022

Correspondence to: Elsayed Ghoneem, ghoneem_84@yahoo.com

Conflict of Interest Statement The authors declare that they have no conflict of interest.

Author Contributions Protocol of the study, study design, methodology, follow-up of the patients, collecting data, data analysis, and writing - original draft preparation: Elsayed Ghoneem, Kalid Ragab, Hussein Oka sha, Mohamed Fathi, Mohamed Hamouda, Reham Soliman, and Ramy Agwa. Statistical analysis, writing - review, and editing: El-sayed Ghoneem and Mohamed Hamouda. Supervision: Gamal Shiha, Hussein Okasha, and Ramy Agwa. The procedure (EUS-guided cystogastrostomy) was done by Hussein Okasha (Endoscopy Unit at Kasr Elini Cairo University), Khalid Ragab (Endos-copy Unit at Theodor Bilharz Research Institute), Elsayed Ghoneem (Endoscopy Unit at Specialized Medical Hospital, Mansoura University, and Egyptian Liver Hospital).

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License